Stockholders’ Deficiency (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Feb. 14, 2024	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock authorized		1,000,000,000		1,000,000,000
Common stock par value		$ 0.01		$ 0.01
Payment of taxes		$ 4	$ 479
Proceeds from Issuance of Private Placement			$ 12,000
Private Placement [Member] | Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price	$ 2.16
Proceeds from Issuance of Private Placement	$ 12,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Vesting of restricted stock units		7,499	678,165
Repurchase of restricted common stock			274,692
Common Stock [Member] | Private Placement [Member] | Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate share of common stock	5,555,555
Restricted Stock Units (RSUs) [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Vesting of restricted stock units		7,499	678,165
Restricted Common Stock [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchase of restricted common stock		2,814	282,171
Payment of taxes		$ 4	$ 479